Driehaus Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4M Sell
167,468
-294
-0.2% -$26.4K 0.11% 243
2025
Q4
$14.6M Buy
+167,762
New +$12.7M 0.1% 236
2025
Q2
Sell
-873,784
Closed -$64M 450
2025
Q1
$64M Buy
873,784
+328,040
+60% +$27.1M 0.62% 41
2024
Q4
$45.1M Buy
+545,744
New +$43M 0.37% 96
2021
Q4
Sell
-80,542
Closed -$6.17M 402
2021
Q3
$6.17M Buy
80,542
+72,071
+851% +$5.79M 0.07% 297
2021
Q2
$657K Buy
+8,471
New +$602K 0.01% 361
2019
Q2
Sell
-7,000
Closed -$346K 496
2019
Q1
$346K Buy
+7,000
New +$317K 0.01% 346
2013
Q3
Sell
-48,206
Closed -$813K 470
2013
Q2
$813K Buy
+48,206
New +$744K 0.04% 360

Other funds holding GMED

Driehaus Capital Management's GMED Position: Q1 2026 in Review

Driehaus Capital Management reduced its Globus Medical (GMED) stake by 0.18% in Q1 2026, selling an estimated $26.4K and leaving 167,468 shares worth $14.4M. The position accounts for 0.11% of the portfolio, ranked #243.

Driehaus Capital Management first reported a position in GMED in Q2 2013 and has held it in 8 quarters since. The position peaked at $64M in Q1 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Driehaus Capital Management held 167,468 shares of Globus Medical worth $14.4M as of Q1 2026.
  • Driehaus Capital Management sold 294 Globus Medical shares in Q1 2026, an estimated $26.4K.
  • Globus Medical made up 0.11% of Driehaus Capital Management's portfolio in Q1 2026, its #243 holding.
  • Driehaus Capital Management first reported a position in Globus Medical in Q2 2013 and has held it in 8 quarters since.
  • Driehaus Capital Management's Globus Medical position peaked at $64M in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.